This was the stock's fourth consecutive day of gains.

Aurora Cannabis sees growth with high-margin medical cannabis, debt cuts, and EBITDA gains. Click here to read an analysis of ACB stock now.

Aurora Cannabis Q4 sales rose 34% to $63.07 million, led by medical cannabis and plant propagation, despite missing earnings estimates.

Aurora Cannabis shares tumbled Wednesday as the Canadian cannabis operator said it expects “temporary declines” in its ...

Read about Aurora Cannabis Inc (ACB:XNAS) stock and today's latest news and financial updates. ACB - Aurora Cannabis Inc News | Morningstar Morningstar brands and products ...

Empowering Canadian innovation—discover, invest, and grow with homegrown tech leaders shaping the future. The 2025 Cantech ...

Cannabis stocks, as measured by the Global Cannabis Stock Index, were quite volatile in 2024. The index dropped 7.5% in ...

Proprietary Genetics to be the Highest Potency Medical Cannabis Products Available on the Market NASDAQ | TSX: ACB EDMONTON, AB, June 24, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ...

Aurora Cannabis (ACB) delivered earnings and revenue surprises of -36.36% and 1.65%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Aurora Cannabis Inc. advanced stock charts by Barron's. View ACB historical stock data and compare to other stocks, and exchanges.

Shares of Aurora Cannabis Inc. ACB rallied 3.95% to $4.47 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.94% to ...